ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,119.69
-0.54%
Dow Jones
38,647.10
-0.17%
Gold vs US Dollar
2,322.56
0.87%
Brent Oil
82.385
0.50%
Bitcoin
66,924.89
0.25%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Alvontech (ALVO) Share Price

ALVO Alvontech

14.28
0.00 (0.00%)
Pre Market
Last Updated: 10:21:31
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Alvontech NASDAQ:ALVO NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.00 0.00 14.28 5.72 15.10 0.00 0.00   09:21:31   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Coml Physical, Biologcl Resh 93.38M -551.73M -2.0938 -6.82 3.76B
 Type  Size  Price  Time  Units 
   0.00  
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore ALVO News
11/06/202409:00GLOBEAlvotech and STADA add to strategic alliance through denosumab partnership
07/06/202409:00GLOBEAlvotech Announces Strategic Refinancing Agreement
29/05/202413:05GLOBEAlvotech to Participate in Jefferies Healthcare Conference in New York, June 5-6, 2024
21/05/202422:15GLOBEAlvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update
21/05/202415:05BWAlvotech and Dr. Reddy’s Enter Into Collaboration for Commercialization of AVT03 (denosumab), a Biosimilar Candidate to Prolia® & Xgeva® in the U.S., Europe and UK
21/05/202413:00GLOBEAlvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a biosimilar candidate to Prolia® & Xgeva® in the U.S., Europe and UK
21/05/202412:13IHMARKETNEWSU.S. Index Futures Open Lower Amid Nasdaq Record, Fed Speeches
Period
Draw mode
Data Downloads for ALVO

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Alvontech Articles